Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-06

Clinical Trial Update: Antibiotics to Decrease Post ERCP Cholangitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating antibiotics to reduce post-ERCP cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Southern California | Conditions: Cholangitis | Phase 4 | Status: UNKNOWN